Prescription Drug Price Negotiation Expansion Act
This bill expands Medicare's authority to negotiate drug prices to cover all brand-name drugs without generic competition (not just the current limited list), caps annual out-of-pocket prescription costs at $2,000 for all insured Americans, and requires pharmaceutical companies to justify price increases exceeding inflation.
Discussion (7)
This would directly affect my community. I have some suggested changes to make it more practical.
The enforcement mechanism needs to be stronger. Without teeth, this becomes another unfunded mandate.
This is long overdue. Other countries have had similar policies for years and the results speak for themselves.
This needs a sunset clause. Pass it as a 5-year pilot and evaluate results before making it permanent.
I'd like to see an amendment adding transparency requirements — the public deserves to know how money is spent.
Great proposal. How does this interact with existing state-level regulations?
Mixed feelings. The goal is right but there are simpler ways to achieve the same outcome with less bureaucracy.